---
input_text: 'Cerebral hemodynamics and oxygenation in adult patients with sickle cell
  disease after stem cell transplantation.Sickle cell disease (SCD) is characterized
  by chronic hemolytic anemia associated with impaired cerebral hemodynamics and oxygen
  metabolism. Hematopoietic stem cell transplantation (HSCT) is currently the only
  curative treatment for patients with SCD. Whereas normalization of hemoglobin levels
  and hemolysis markers has been reported after HSCT, its effects on cerebral perfusion
  and oxygenation in adult SCD patients remain largely unexplored. This study investigated
  the effects of HSCT on cerebral blood flow (CBF), oxygen delivery, cerebrovascular
  reserve (CVR), oxygen extraction fraction (OEF), and cerebral metabolic rate of
  oxygen (CMRO2 ) in 17 adult SCD patients (mean age: 25.0 +- 8.0, 6 females) before
  and after HSCT and 10 healthy ethnicity-matched controls (mean age: 28.0 +- 8.8,
  6 females) using MRI. For the CVR assessment, perfusion scans were performed before
  and after acetazolamide as a vasodilatory stimulus. Following HSCT, gray and white
  matter (GM and WM) CBF decreased (p < .01), while GM and WM CVR increased (p < .01)
  compared with the baseline measures. OEF and CMRO2 also increased towards levels
  in healthy controls (p < .01). The normalization of cerebral perfusion and oxygen
  metabolism corresponded with a significant increase in hemoglobin levels and decreases
  in reticulocytes, total bilirubin, and LDH as markers of hemolysis (p < .01). This
  study shows that HSCT results in the normalization of cerebral perfusion and oxygen
  metabolism, even in adult patients with SCD. Future follow-up MRI scans will determine
  whether the observed normalization of cerebral hemodynamics and oxygen metabolism
  prevents new silent cerebral infarcts.'
raw_completion_output: |-
  primary_disease: Sickle cell disease (SCD)

  medical_actions: Hematopoietic stem cell transplantation (HSCT); MRI scans; acetazolamide as a vasodilatory stimulus

  symptoms: chronic hemolytic anemia; impaired cerebral hemodynamics; impaired oxygen metabolism; decreased cerebral blood flow (CBF); reduced cerebrovascular reserve (CVR); altered oxygen extraction fraction (OEF); change in cerebral metabolic rate of oxygen (CMRO2)

  chemicals: acetazolamide

  action_annotation_relationships: Hematopoietic stem cell transplantation (HSCT) TREATS chronic hemolytic anemia IN Sickle cell disease (SCD); Hematopoietic stem cell transplantation (HSCT) TREATS impaired cerebral hemodynamics IN Sickle cell disease (SCD); Hematopoietic stem cell transplantation (HSCT) TREATS impaired oxygen metabolism IN Sickle cell disease (SCD); acetazolamide (as a vasodilatory stimulus) TREATS reduced cerebrovascular reserve (CVR) IN Sickle cell disease (SCD); MRI scans MONITOR change in cerebral metabolic rate of oxygen (CMRO2) IN Sickle cell disease (SCD); MRI scans MONITOR altered oxygen extraction fraction (OEF) IN Sickle cell disease (SCD)
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  MRI scans MONITOR altered oxygen extraction fraction (OEF) IN Sickle cell disease (SCD)

  ===

extracted_object:
  primary_disease: MONDO:0007374
  medical_actions:
    - MAXO:0000747
    - MRI scans
    - acetazolamide as a vasodilatory stimulus
  symptoms:
    - HP:0004870
    - impaired cerebral hemodynamics
    - impaired oxygen metabolism
    - decreased cerebral blood flow (CBF)
    - reduced cerebrovascular reserve (CVR)
    - altered oxygen extraction fraction (OEF)
    - change in cerebral metabolic rate of oxygen (CMRO2)
  chemicals:
    - CHEBI:27690
  action_annotation_relationships:
    - subject: MAXO:0000747
      predicate: TREATS
      object: HP:0004870
      qualifier: MONDO:0011382
    - subject: <Hematopoietic stem cell transplantation>
      predicate: <TREATS>
      object: <impaired cerebral hemodynamics>
      qualifier: <Sickle cell disease>
      subject_extension: <Hematopoietic stem cell transplantation>
    - subject: <Hematopoietic stem cell transplantation>
      predicate: <TREATS>
      object: <impaired oxygen metabolism>
      qualifier: <Sickle cell disease>
      subject_qualifier: <N/A>
      object_qualifier: <N/A>
      subject_extension: <Hematopoietic stem cell transplantation>
      object_extension: <N/A>
    - subject: vasodilatory stimulus
      predicate: TREATS
      object: reduced cerebrovascular reserve (CVR)
      qualifier: MONDO:0007374
      subject_extension: CHEBI:27690
    - subject: <MRI scans>
      predicate: <MONITOR>
      object: <change in cerebral metabolic rate of oxygen (CMRO2)>
      qualifier: MONDO:0007374
      subject_extension: <MRI scans>
    - subject: MRI scans
      predicate: MONITOR
      object: altered oxygen extraction fraction (OEF)
      qualifier: MONDO:0007374
named_entities:
  - id: MONDO:0011382
    label: sickle cell disease
  - id: MONDO:0100096
    label: SARS-CoV-2
  - id: MONDO:0007374
    label: Sickle cell disease (SCD)
  - id: HP:0100602
    label: Preeclampsia
  - id: HP:0001511
    label: Intrauterine growth restriction
  - id: CHEBI:44423
    label: Hydroxyurea (HU)
  - id: CHEBI:35143
    label: Haemoglobin (Hb)
  - id: HP:0001622
    label: Preterm delivery
  - id: CHEBI:50858
    label: corticosteroids
  - id: HP:0032654
    label: Endothelial dysfunction
  - id: HP:0012418
    label: Hypoxia
  - id: HP:0001409
    label: Portal hypertension
  - id: MAXO:0001001
    label: Gene therapies
  - id: MAXO:0000756
    label: Transfusion
  - id: MAXO:0000747
    label: Hematopoietic stem cell transplantation
  - id: MAXO:0001298
    label: therapy
  - id: MAXO:0009047
    label: Total hip replacement (THR)
  - id: CHEBI:22720
    label: Benzodiazepines
  - id: MONDO:0006079
    label: Acute chest syndrome (ACS)
  - id: CHEBI:24859
    label: Iodine
  - id: MONDO:0005632
    label: Acute chest syndrome
  - id: CHEBI:17334
    label: penicillin
  - id: MAXO:0000118
    label: immunizations
  - id: HP:0001903
    label: anemia
  - id: HP:0001297
    label: stroke
  - id: HP:0012532
    label: Chronic pain
  - id: CHEBI:3216
    label: Buprenorphine
  - id: HP:0001518
    label: Low birth weight
  - id: MAXO:0001006
    label: Full blood count
  - id: MAXO:0000825
    label: Reticulocyte count
  - id: MAXO:0000427
    label: Brain magnetic resonance imaging (MRI)
  - id: HP:0012592
    label: albuminuria
  - id: HP:0100543
    label: cognitive dysfunction
  - id: HP:0000739
    label: anxiety
  - id: HP:0010783
    label: Redness
  - id: CHEBI:33281
    label: antibiotics
  - id: MONDO:0009693
    label: Multiple Myeloma
  - id: CHEBI:145536
    label: Motixafortide
  - id: CHEBI:114786
    label: sodium metabisulfite
  - id: CHEBI:15365
    label: aspirin
  - id: HP:0000093
    label: Proteinuria
  - id: HP:0012622
    label: CKD
  - id: MAXO:0000969
    label: optical coherence tomography (OCT)
  - id: HP:0000505
    label: visual impairment
  - id: CHEBI:28901
    label: busulfan
  - id: CHEBI:82557
    label: treosulfan
  - id: CHEBI:9570
    label: thiotepa
  - id: HP:0100603
    label: Hypertensive disorder of pregnancy (HDP)
  - id: CHEBI:26308
    label: unweighted polygenic risk score (PRS)
  - id: CHEBI:35480
    label: Analgesics
  - id: HP:0012213
    label: Decreased glomerular filtration rate
  - id: HP:0012398
    label: Peripheral oedema
  - id: HP:0001685
    label: Cardiac fibrosis
  - id: MONDO:0005570
    label: hematologic diseases
  - id: HP:0001871
    label: hematologic diseases
  - id: HP:0001712
    label: Left ventricular hypertrophy
  - id: HP:0007760
    label: SCD
  - id: MAXO:0000149
    label: Hematopoietic cell transplant (HCT)
  - id: MAXO:0010203
    label: Echocardiography
  - id: HP:0012531
    label: Pain
  - id: CHEBI:51371
    label: muscle relaxants
  - id: HP:0002140
    label: Arterial ischemic stroke
  - id: MONDO:0019402
    label: Thalassemia major
  - id: MAXO:0000536
    label: Chorionic villus sampling (CVS)
  - id: MONDO:0020380
    label: Sickle cell anemia (SCA)
  - id: MONDO:0005161
    label: Human papillomavirus (HPV) infection
  - id: MAXO:0000759
    label: HPV vaccination
  - id: MAXO:0000447
    label: Surgical removal
  - id: HP:0033138
    label: Right atrial thrombus
  - id: HP:0000989
    label: pruritus
  - id: MAXO:0010041
    label: skin grafting
  - id: MAXO:0000058
    label: Pharmacotherapies
  - id: HP:0001513
    label: obesity
  - id: CHEBI:4027
    label: Cyclophosphamide
  - id: HP:0002617
    label: vasculopathy
  - id: MAXO:0000068
    label: Transplantation
  - id: HP:0004870
    label: chronic hemolytic anemia
  - id: CHEBI:27690
    label: acetazolamide
